Pocket-Sized clot check could make blood thinner safer

NCT ID NCT07012291

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests a small, battery-powered device called ClotChek™ that measures how fast a patient's blood clots using a fresh drop of blood. Researchers want to see if it can tell the difference between people on common blood thinners (rivaroxaban or apixaban) and those not on any. About 150 adults aged 18 to 80 will take part, and the goal is to make monitoring blood thinners quicker and easier at the bedside.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Perosphere ClotChek™ coagulometer (device)
What this could lead to
If successful, this device could give doctors a fast, bedside way to check blood-thinner levels, helping to reduce bleeding or clotting risks.
What could go wrong
This is an early performance study with only 150 participants, so the device may not be accurate enough for all patients or settings.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for COAGULATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Bassett Research Institute - Center for Clinical Research

    RECRUITING

    Cooperstown, New York, 13326, United States

  • Eastern Vascular Associates

    RECRUITING

    Denville, New Jersey, 07834, United States

  • Perosphere Technologies Inc

    RECRUITING

    Danbury, Connecticut, 06811, United States

  • Perosphere Technologies Inc

    RECRUITING

    Rockville, Maryland, 20850, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.